2022年3期
刊物介紹
Cancer Biology & Medicine is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: ● Cancer epigenetics ● Cancer stem cell ● Improved in vivo and in vitro cancer models ● Cancer prevention and epidemiology ● Biomarkers for predicting drug response ● Mechanism of drug sensitivity and resistance ● New approaches for cancer detection and diagnosis ● Oncology clinical trials ● Targeted therapy ● Multidisciplinary treatment for cancer Author benefits: ● Easy online submission via Editorial Manager ● Efficient and professional peer-review by expert referees from around the world ● Rapid pre-print online publication ● No charge for publication and Open Access ● International visibility - the journal is available free online
Cancer Biology & Medicine
EDITORIAL
PERSPECTIVE
REVIEW
- Modulating microRNAs in cancer: next-generation therapies
- The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
- Tumor organoids for cancer research and personalized medicine
- Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
ORIGINAL ARTICLE
- The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma
- Safety and efficacy of anti-EGFR monoclonal antibody(SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
- Dietary fat intake and liver cancer risk: A prospective cohort study in Chinese women